These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc). Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483 [TBL] [Abstract][Full Text] [Related]
6. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. Gomes MP; Millen TA; Ferreira PS; e Silva NL; Vieira TC; Almeida MS; Silva JL; Cordeiro Y J Biol Chem; 2008 Jul; 283(28):19616-25. PubMed ID: 18456654 [TBL] [Abstract][Full Text] [Related]
7. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. Lehmann S; Harris DA J Biol Chem; 1997 Aug; 272(34):21479-87. PubMed ID: 9261166 [TBL] [Abstract][Full Text] [Related]
8. Cell biological studies of the prion protein. Harris DA Curr Issues Mol Biol; 1999; 1(1-2):65-75. PubMed ID: 11475702 [TBL] [Abstract][Full Text] [Related]
10. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition. Taguchi Y; Schätzl HM Prion; 2013; 7(6):452-6. PubMed ID: 24401595 [TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. Daude N; Marella M; Chabry J J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373 [TBL] [Abstract][Full Text] [Related]
13. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation. Bate C; Williams A J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283 [TBL] [Abstract][Full Text] [Related]
14. Antagonistic roles of the N-terminal domain of prion protein to doppel. Sakaguchi S Prion; 2008; 2(3):107-11. PubMed ID: 19158506 [TBL] [Abstract][Full Text] [Related]
15. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio. Katorcha E; Makarava N; Savtchenko R; Baskakov IV Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925 [TBL] [Abstract][Full Text] [Related]
16. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. Horiuchi M; Caughey B EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660 [TBL] [Abstract][Full Text] [Related]
17. Evolving views in prion glycosylation: functional and pathological implications. Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773 [TBL] [Abstract][Full Text] [Related]
18. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion. Rigter A; Bossers A J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922 [TBL] [Abstract][Full Text] [Related]
19. Prion protein self-peptides modulate prion interactions and conversion. Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977 [TBL] [Abstract][Full Text] [Related]
20. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation. Norstrom EM; Mastrianni JA J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]